SPDR S&P Pharmaceuticals ETF
XPH
XPH
80 hedge funds and large institutions have $143M invested in SPDR S&P Pharmaceuticals ETF in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
42% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 26
Holders
80
Holding in Top 10
–
Calls
$2.29M
Puts
–
Top Buyers
| 1 | +$10.9M | |
| 2 | +$6.24M | |
| 3 | +$4.32M | |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$1.54M |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$1.44M |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$1.51M | |
| 3 | -$1.48M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$1.15M |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$868K |